Applied’s lead candidate is a selective aldose reductase inhibitor called govorestat, an asset that failed to hit primary endpoints in late-stage trials for a progressive neuromuscular disease called ...
Abstract: This study aims to delineate the research trajectory, key foci, and emergent trends in the application of VLEs (VLEs) to undergraduate education. Utilizing bibliometric techniques with ...